349 related articles for article (PubMed ID: 22954445)
1. Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects.
Mi Y; Zhao J; Feng SS
Int J Pharm; 2012 Nov; 438(1-2):98-106. PubMed ID: 22954445
[TBL] [Abstract][Full Text] [Related]
2. Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer.
Mi Y; Zhao J; Feng SS
J Control Release; 2013 Aug; 169(3):185-92. PubMed ID: 23403395
[TBL] [Abstract][Full Text] [Related]
3. Formulation of Docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy.
Mi Y; Liu Y; Feng SS
Biomaterials; 2011 Jun; 32(16):4058-66. PubMed ID: 21396707
[TBL] [Abstract][Full Text] [Related]
4. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
[TBL] [Abstract][Full Text] [Related]
5. Development of docetaxel-loaded vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats.
Muthu MS; Kulkarni SA; Liu Y; Feng SS
Nanomedicine (Lond); 2012 Mar; 7(3):353-64. PubMed ID: 22329606
[TBL] [Abstract][Full Text] [Related]
6. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy.
Anbharasi V; Cao N; Feng SS
J Biomed Mater Res A; 2010 Sep; 94(3):730-43. PubMed ID: 20225211
[TBL] [Abstract][Full Text] [Related]
8. Addition of TPGS to folate-conjugated polymer micelles for selective tumor targeting.
Zhao H; Yung LY
J Biomed Mater Res A; 2009 Nov; 91(2):505-18. PubMed ID: 18985763
[TBL] [Abstract][Full Text] [Related]
9. A core cross-linked polymeric micellar platium(IV) prodrug with enhanced anticancer efficiency.
Hou J; Shang J; Jiao C; Jiang P; Xiao H; Luo L; Liu T
Macromol Biosci; 2013 Jul; 13(7):954-65. PubMed ID: 23744619
[TBL] [Abstract][Full Text] [Related]
10. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z
J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552
[TBL] [Abstract][Full Text] [Related]
11. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial delivery of Crizotinib-Palbociclib-Sildenafil using TPGS-PLA micelles for improved cancer treatment.
de Melo-Diogo D; Gaspar VM; Costa EC; Moreira AF; Oppolzer D; Gallardo E; Correia IJ
Eur J Pharm Biopharm; 2014 Nov; 88(3):718-29. PubMed ID: 25308930
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of a novel drug delivery: Soluplus
Ding Y; Wang C; Wang Y; Xu Y; Zhao J; Gao M; Ding Y; Peng J; Li L
Drug Dev Ind Pharm; 2018 Sep; 44(9):1409-1416. PubMed ID: 29718714
[TBL] [Abstract][Full Text] [Related]
14. Vitamin E TPGS as a molecular biomaterial for drug delivery.
Zhang Z; Tan S; Feng SS
Biomaterials; 2012 Jun; 33(19):4889-906. PubMed ID: 22498300
[TBL] [Abstract][Full Text] [Related]
15. TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy.
Zhang J; Li Y; Fang X; Zhou D; Wang Y; Chen M
Int J Pharm; 2014 Dec; 476(1-2):185-98. PubMed ID: 25223472
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of pH-responsive folate-functionalized poloxamer 407-TPGS-mixed micelles on targeted delivery of anticancer drugs.
Butt AM; Mohd Amin MC; Katas H
Int J Nanomedicine; 2015; 10():1321-34. PubMed ID: 25709451
[TBL] [Abstract][Full Text] [Related]
17. Self-controlled release of Oxaliplatin prodrug from d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy.
Liang C; Wang H; Zhang M; Cheng W; Li Z; Nie J; Liu G; Lian D; Xie Z; Huang L; Zeng X
J Colloid Interface Sci; 2018 Sep; 525():1-10. PubMed ID: 29679795
[TBL] [Abstract][Full Text] [Related]
18. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
Zhang Z; Feng SS
Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
[TBL] [Abstract][Full Text] [Related]
19. Vitamin E (D-alpha-tocopheryl-co-poly(ethylene glycol) 1000 succinate) micelles-superparamagnetic iron oxide nanoparticles for enhanced thermotherapy and MRI.
Chandrasekharan P; Maity D; Yong CX; Chuang KH; Ding J; Feng SS
Biomaterials; 2011 Aug; 32(24):5663-72. PubMed ID: 21550654
[TBL] [Abstract][Full Text] [Related]
20. Design, preparation and characterization of pH-responsive prodrug micelles with hydrolyzable anhydride linkages for controlled drug delivery.
Seetharaman G; Kallar AR; Vijayan VM; Muthu J; Selvam S
J Colloid Interface Sci; 2017 Apr; 492():61-72. PubMed ID: 28068545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
